Sodium Hyaluronate

Sodium Hyaluronate

Cat Number
API9067327
CAS Number
9067-32-7

If you have any other questions, please contact our experts.

CAS Number
9067-32-7
EINECS
618-620-0
Storage
2-8℃
Molecular Formula
(C14H22NNaO11)n
Appearance
White solid
General Description
Sodium Hyaluronate is the sodium salt derivative of hyaluronic acid (HA), which is widely distributed in connective, epithelial, and neural tissues. Sodium Hyaluronate is known for its viscoelastic properties and can absorb and retain high amounts of water. It is used in pharmaceutical and biomedical applications as an ultra-pure base material for manufacturing ocular, orthopedic, and tissue engineering products.
Mechanism of Action
As a major component of the extracellular matrix, Sodium Hyaluronate acts as a lubricant and structural scaffold within connective tissues. It works by creating a hydrating film on the skin surface that can attract and hold water molecules. This film helps increase cell migration and promote healing while helping ease movement in joint tissues. Sodium hyaluronate attracts water ions to help stabilize the surrounding tissues osmotically. This substance can act as a shock absorber and provide diffusion screening.
Application
Sodium hyaluronate plays a pivotal role in orthopedic research focused on viscosupplementation strategies aimed at restoring joint function and movement. In ophthalmic surgery and artificial tear lubricants, it is valued for its excellent biocompatibility properties. Sodium hyaluronate has been incorporated into specialty bandages, injectables, sustained-release matrices, and premium cosmetic products targeting increased skin hydration.

HMW hyaluronic acid (HA) is anti-inflammatory, anti-elastase, and barrier-protective. Low-molecular fragments produced during inflammation are pro-inflammatory and pro-angiogenic. In disorders of the upper-airways, randomized controlled trials showed that HMW HA, given by nebulization or intranasally, improved mucociliary clearance, reduced biofilm formation, and decreased post-operative healing time after functional endoscopic sinus surgery with excellent tolerability.
In COPD, experimental and clinical evidence suggests cigarette smoke reduces pulmonary HA levels. In animals and humans, treatment with exogenous aerosolized 0.01% HMW HA reduced urinary and sputum isodesmosine without any adverse events. In cystic fibrosis and bronchiectasis, four prospective studies found that combining 0.1% HMW HA with 7% hypertonic saline solution improved tolerability (reduced cough, throat irritation and salty taste) without affecting its ability to increase sputum expectoration.

Fig. 1 Effects of short-fragment hyaluronic acid (HA) on a lung injury. (Máiz Carro L.; <i>et al</i>. 2020) Fig. 1 Effects of short-fragment hyaluronic acid (HA) on a lung injury. (Máiz Carro L.; et al. 2020)

References

  1. Máiz Carro L.; et al. Use of hyaluronic acid (HA) in chronic airway diseases. Cells, 2020, 9(10): 2210.

Wang X et al. created a self-powered "all-in-one" wound dressing by laminating a HA-based supercapacitor onto an electroactive hydrogel. PGM electrolyte and PEDOT:PSS-doped Conductive-PGM electrodes were cross-linked via freeze-thaw cycles, yielding 0.34 MPa strength, 380% swelling and 21 mF per square centimeter capacitance with 97% retention after 500 cycles. The charged device delivered 30 μA per square centimeter ES directly to the wound without external cables.
In vitro, the dressing showed <5% hemolysis, 20 mm S. aureus inhibition and 90% NIH3T3 viability. Under ES, fibroblast proliferation rose to 270%. ES-treated wounds on murine full-thickness defects healed by day 16 compared to non-ES or gauze controls which remained open. Histological analysis showed thicker granulation tissue formation, increased neovessel density and more hair follicles in ES group mice. This confirms HA release from the ES and ES promotes accelerated healing synergistically.

Fig. 2 Preparation, design, and working mechanism of a HA-based supercapacitor. (Wang X.; <i>et al</i>. 2023) Fig. 2 Preparation, design, and working mechanism of a HA-based supercapacitor. (Wang X.; et al. 2023)

References

  1. Wang X.; et al. Integrating supercapacitor with sodium hyaluronate based hydrogel as a novel All-In-One wound Dressing: Self-Powered electronic stimulation. Chemical Engineering Journal, 2023, 452: 139491.

What pH range is Sodium Hyaluronate stable in?

Neutral pH. Highly acidic/basic conditions will degrade the polymer and it will lose viscosity.

Can Sodium Hyaluronate bind with other molecules?

Yes, it can complex with proteins/polymers to modulate active pharmaceutical ingredient release profiles.

Is this product pharmacopeia compliant?

Yes, we offer pharmacopeia matched grades for worldwide biomedicine use.

What are the recommended storage conditions?

Cool and dry places, generally 2°-8℃, in well sealed containers.
You Might Also Like
Indobufen
Indobufen

Cat NO.: API63610082
CAS NO.: 63610-08-2

View Details
Troxerutin(Oral/Injection)
Troxerutin(Oral/Injection)

Cat NO.: API7085554
CAS NO.: 7085-55-4

View Details
Dabigatran Etexilate Mesylate
Dabigatran Etexilate Mesylate

Cat NO.: API872728819
CAS NO.: 872728-81-9

View Details
Dabigatran Etexilate
Dabigatran Etexilate

Cat NO.: API211915069
CAS NO.: 211915-06-9

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top